Fortera Capital
孚腾资本
Fortera Capital (孚腾资本) shows up in elsewhere's corpus as an active Chinese institutional investor in AI and robotics, though the material covers its deals rather than the fund itself — its founding details, size, and team aren't in the corpus. What's visible is the footprint: in November 2025 it co-led Infinigence AI's nearly 500 million yuan round (alongside Zhuhai Sci-Tech Group) to build infrastructure for the agentic era, per an Oasis Capital announcement ; a month later it co-led North Ocean Photonics' new Series C via its "元创未来基金" (Yuan Chuang Future Fund) vehicle, together with SDIC XianDao's AI master fund, to scale wafer-level optical R&D . By April 2026 it had joined the investor ranks of two embodied-AI standouts — Tashi Zhihang's $455M pre-A alongside Shanghai SDIC XianDao, Beijing's robotics industry fund and TCL Industrial Investment , and Sudu Tech, whose cap table also counts Oasis, CATL, Alibaba, Hillhouse, Tencent, Ant, IDG and BlueRun . Related coverage: FreeS Fund pieces in the corpus name-drop adjacent early-stage investors but are about FreeS itself, not Fortera.
AI-generated — may contain errors, please verify.
Coverage
Raybeam Medical Raises Tens of Millions in Angel Round Led by Dalton Venture to Advance Laparoscopic Intraoperative Radiation Therapy Robot
Recently, **Raysure Medical (hereinafter referred to as "Raysure"), an innovative company developing intraoperative radiotherapy robots for endoscopic surgery, announced the completion of a multimillion-yuan angel funding round**. The round was led by Dalton Venture, with participation from Shuimu Tsinghua Alumni Fund, Fortera Capital, and HETANG Venture Capital. The proceeds will be used primarily for animal and clinical trials, product technology iteration, core team expansion, and technology platform development.
"Deep Principle" Closes Nearly RMB 1 Billion in Total Series A Funding, Linear Capital Continues to Increase Stake | Linear Portfolio
Leading globally in AI scientist capabilities and industrial implementation.
Zero real-world training data, nearly 100% success rate! Sudu Tech debuts self-developed system #Sudo R1 | Oasis Vitality
Unlocking a New Paradigm in Embodied Artificial Intelligence
$2 Billion Startup SurgeTech's Debut in Embodied AI Is a Blockbuster: Zero Real-World Data, Zero-Shot, 98% First-Attempt Grasp Success Rate | BlueRun Ventures Family Headlines
Sudo Tech's Embodied Model #Sudo R1 Makes Its Debut
BlueRun Ventures' Angel Project Tashi Zhihang Closes $455M Pre-A Round to Build Robots That "Actually Work and Actually Ship" | BlueRun Family
Let China's Embodied Intelligence Take the World Stage
16 Companies Making Agents More Useful Are Raising Funding
Product-Agent Fit
MaKe | MaHui Member "Kunyou Photonics" Completes New Series C Funding Round to Accelerate Scaling of Wafer-Level Optical R&D and Manufacturing Capabilities
Source Code Capital participated in J&T Global Express's Series B+ funding round in 2021.
Infinigence AI Closes Nearly 500 Million Yuan Funding Round to Build Infrastructure for the Agentic Era | Oasis Vitality
Councilor Vitality







